Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 5, 1997, Pages 519-521

  Pronzato, Paolo ^a   Vigani, Antonella ^a   Pensa, Floriana ^a   Vanoli, Maurizio ^a   Tani, Francesco ^a   Vaira, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ifosfamide; Mesna; Urothelial cancer

Indexed keywords

ANTIEMETIC AGENT; IFOSFAMIDE; MESNA; SEROTONIN ANTAGONIST;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HAIR LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PHASE 2 CLINICAL TRIAL; PROPHYLAXIS; STOMATITIS; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; VOMITING;

ADMINISTRATION, ORAL; AGED; ALOPECIA; AMBULATORY CARE; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW; CARCINOMA, TRANSITIONAL CELL; CAUSE OF DEATH; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; EXPECTORANTS; FEASIBILITY STUDIES; FEMALE; HUMANS; IFOSFAMIDE; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; MESNA; MIDDLE AGED; NAUSEA; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; VOMITING;

EID: 0030810884     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199710000-00018     Document Type: Article

References (10)

1. De Carli A, La Vecchia C. Cancer Mortality in Italy 1991. Tumori 1994;80:405-15.
2. Sternberg CN. The treatment of advanced bladder cancer. Ann Oncol 1995;6:113-26.
3. Miller RS, Torti FM. Chemotherapy of advanced transitional-cell carcinoma of the bladder. Cancer Chemother Pharinacol 1992;30(suppl):S99-S110.
4. Logothetis CJ, Dexeus FH, Finn L, et al. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with mctastatic urothelial tumors. J Clin Oncol 1990; 8:1050-55.
5. Pronzato P, Landucci M, Vaira F, Vigani A, Bertelli G. Carboplatin, methotrexate, and vinblastine in outpatients with advanced transitional cell carcinoma of the bladder. Am J Clin Oncol 1995; 18:223-5.
6. Brawell VH, Muridsen HT, Santoro A, et al. Cyclophosphainide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer din Oncol 1987; 23:311-6.
7. Buzdar AU, Legha SS, Tashima CK, et al. Ifosfamide versus cyclophosphamide in combination drug therapy for metastatic breast cancer. Cancer Treat Rep 1979;63:115-20.
8. Witte R, Lochere P, Dreicer R, et al. Ifosfamide in advanced urothelial carcinoma. An ECOG trial. Proc Am Soc Clin Oncol 1993; 12:230.
9. Gad-EI-Mawla N, Hamza M, Zikri Z, El-Serafi M, El-Khodary A, Khaled H, Abdel-Wareth A. Chemotherapy in invasive carcinoma of the bladder: a review of the phase II trials in Eaypt. Ada Oncol 1989;28:73-6.
10. Einhorn LH, Roth BJ, Ansari R, Dreiser R, Gonin R, Loehrer PJ. Phase II trial of Vinblastine, Ifosfamide and Gallium combination chemotherapy in metastatic urothelial carcinoma. J Clin Oncol 1994; 12:2271-6.